Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

June 30, 2019

Conditions

Breast Cancer

Interventions

DRUG

Duavee

Once daily tablet of Duavee (Bazedoxifene (20 mg) plus conjugated estrogen (0.45 mg))

Trial Locations (2)

University of Kansas Medical Center, Kansas City

University of Kansas Medical Center Breast Cancer Prevention Center, Westwood